Viewing Study NCT01762761


Ignite Creation Date: 2025-12-24 @ 11:59 AM
Ignite Modification Date: 2026-05-31 @ 5:26 PM
Study NCT ID: NCT01762761
Status: COMPLETED
Last Update Posted: 2019-12-03
First Post: 2012-12-19
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Eltrombopag Phase III Study In Chinese Chronic ITP Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Purpura, Thrombocytopenic, Idiopathic and Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None eltrombopag View
None TPO-R agonist View
None Chronic ITP View
None ETB115 View
None Chinese chronic ITP patients View